Management of hepatic metastases from colorectal cancer
- PMID: 20011304
- PMCID: PMC2780092
- DOI: 10.1055/s-2005-916282
Management of hepatic metastases from colorectal cancer
Abstract
The majority of hepatic metastases in the United States occur in patients with a primary colorectal malignancy. Advances in technology combined with increasing surgeon experience have broadened the treatment options available for hepatic metastases from colorectal cancer. Surgical resection is the most effective therapy for metastatic colorectal cancer isolated to the liver. The aim of this article is to discuss the role of locally aggressive treatment options including resection, ablation, and regional chemotherapy in the management of patients with metastases from colorectal cancer.
Keywords: Hepatic metastases; colorectal cancer; hepatic ablation; hepatic resection.
Figures
References
-
- Jemal A, Thomas A, Murray T, et al. Cancer statistics. CA Cancer J Clin. 2002;52:23–47. - PubMed
-
- Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer. 1969;23:198–202. - PubMed
-
- Cady B, Monson D, Swinton N. Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet. 1970;131:697–700. - PubMed
-
- Scoggins C, Meszoely I, Blanke C, et al. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol. 1999;6:651–657. - PubMed
-
- Ohlsson B, Tranberg K, Lundstedt C, et al. Detection of hepatic metastases in colorectal cancer: a prospective study of laboratory and imaging methods. Eur J Surg. 1993;159:275–281. - PubMed
